Chair’s Opening Remarks - HER2-Targeted Therapies

Skip to content

34161 - 3rd HER2 - Targeted Therapies Summit

This event has been cancelled

Explore All Therapeutic Modalities across CLDN18.2, CLDN6, CLDN1:
Claudin-Targeted Therapies Summit ➤

Explore HER-2 & Other Targets at:
3rd ADC Target Selection Summit ➤

Home
About
- About Event
- Hanson Wade
Partner
- Partnership Opportunities
Take Part
- Register Interest
- Contact Us

Chair’s Opening Remarks

Time: 8:50 am
day: Conference Day Two

Speakers:

Gail Lewis

VENUE

Hilton Boston Logan Airport
One Hotel Dr,
Boston, MA
02128,
United States

LOCATION

OUR CONTACT DETAILS

Phone
UK: +44 (0)20 3141 8700
US: +1 617 455 4188

Email
info@hansonwade.com

JOIN OUR TEAM

We are always looking for ambitious people to join our team. You'll have opportunities to learn quickly, advance your career, and to meaningfully impact our customers and our business.

Click here to learn about careers.

ABOUT US

Hanson Wade specializes in scientific research across a comprehensive range of distinctive R&D areas. We deliver insight and connections to facilitate safe and effective drug development for more personalized and targeted patient populations.

EXPLORE OUR PRODUCTS

Conferences	Beacon
Searchlight	Intelligence

SEARCH

Search

ORGANIZED BY

Terms & Conditions

Privacy Policy

A Hanson Wade Group Company

HWG

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.

Scroll To Top